دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 30,000,000 تومان- قیمت ویژه : 8,250,000تومان
دسترسی یکماهه به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 31 ﺭﻭﺯ
قیمت : 3,000,000 تومان- قیمت ویژه : 1,250,000تومان
Focus on atherothrombosis mechanisms and ischaemic heart disease management
doi : 10.1093/eurheartj/ehaf528
Volume 46, Issue 33, 1 September 2025
Stakeholder meeting report for ENHANCE CVH: a trial to improve maternal and child cardiovascular health in Nigeria
REACT initiative: early cure of atherosclerosis through precision prevention
Ferroptosis in cardiovascular disease: regulatory mechanisms and therapeutic implications
Distinct inflammatory pathways shape atherosclerosis in different vascular beds
Optimal medical care and coronary flow capacity-guided myocardial revascularization vs usual care for chronic coronary artery disease: the CENTURY trial
A CENTURY of progress: using physiology-based imaging to improve patient outcomes in chronic coronary artery disease
Adverse pregnancy outcomes and long-term risk of stroke: a Swedish nationwide co-sibling study
Early and multicomponent intervention after adverse pregnancy outcomes: an opportunity to win hearts and minds
Family history of aortic dissection in fibrillin-1 pathogenic variant
Potential measures to enhance understanding of coffee-drinking timing and mortality
Assessment and characterization of circadian and temporal eating patterns for precision nutrition
Acquired von Willebrand syndrome caused by paravalvular prosthetic mitral regurgitation
Giant ascending aortic aneurysm in a 6-year-old boy with LOX gene mutation associated with familial thoracic aortic aneurysm type 10
Weekly Journal Scan: A global observational study shows how modifying five cardiovascular risk factors at midlife may affect lifespan and healthspan
Correction to: Optimal medical care and coronary flow capacity-guided myocardial revascularization vs usual care for chronic coronary artery disease: the CENTURY trial
